mdlinx mdlinx
Rheumatology Articles on MDLinx
Latest (20) Full Text Top Read since last login Focus on Spondylarthropathies Article Summary

Evidence-based Diagnostics: Adult Septic Arthritis Full Text
Academic Emergency Medicine, 08/22/2011  Evidence Based Medicine

Carpenter CR et al. – Recent joint surgery or cellulitis overlying a prosthetic hip or knee were the only findings on history or physical examination that significantly alter the probability of nongonococcal septic arthritis. Extreme values of sWBC (>50 × 109/L) can increase, but not decrease, the probability of septic arthritis. Future ED–based diagnostic trials are needed to evaluate the role of clinical gestalt and the efficacy of nontraditional synovial markers such as lactate.

Methods
  • Two electronic search engines (PUBMED and EMBASE) were used in conjunction with a selected bibliography and scientific hand search.
  • Inclusion criteria included adult trials of patients presenting with monoarticular complaints if they reported sufficient detail to reconstruct partial or complete 2 × 2 contingency tables for experimental diagnostic test characteristics using an acceptable criterion standard.
  • Evidence was rated by two investigators using the Quality Assessment Tool for Diagnostic Accuracy Studies (QUADAS)
  • When more than one similarly designed trial existed for a diagnostic test, meta–analysis was conducted using a random effects model.
  • Interval likelihood ratios (LRs) were computed when possible.
  • To illustrate one method to quantify theoretical points in the probability of disease whereby clinicians might cease testing altogether and either withhold treatment (test threshold) or initiate definitive therapy in lieu of further diagnostics (treatment threshold), an interactive spreadsheet was designed and sample calculations were provided based on research estimates of diagnostic accuracy, diagnostic risk, and therapeutic risk/benefits.

Results
  • The prevalence of nongonococcal septic arthritis in ED patients with a single acutely painful joint is approximately 27% (95% confidence interval [CI]=17% to 38%).
  • With the exception of joint surgery (positive likelihood ratio [+LR]=6.9) or skin infection overlying a prosthetic joint (+LR=15.0), history, physical examination, and serum tests do not significantly alter posttest probability.
  • Serum inflammatory markers such as white blood cell (WBC) counts, erythrocyte sedimentation rate (ESR), and C–reactive protein (CRP) are not useful acutely.
  • The interval LR for synovial white blood cell (sWBC) counts of 0 × 109–25 × 109/L was 0.33; for 25 × 109–50 × 109/L, 1.06; for 50 × 109–100 × 109/L, 3.59; and exceeding 100 × 109/L, infinity.
  • Synovial lactate may be useful to rule in or rule out the diagnosis of septic arthritis with a +LR ranging from 2.4 to infinity, and negative likelihood ratio (–LR) ranging from 0 to 0.46.
  • Rapid polymerase chain reaction (PCR) of synovial fluid may identify the causative organism within 3 hours.
  • Based on 56% sensitivity and 90% specificity for sWBC counts of >50 × 109/L in conjunction with best–evidence estimates for diagnosis–related risk and treatment–related risk/benefit, the arthrocentesis test threshold is 5%, with a treatment threshold of 39%.

Read this article in Academic Emergency Medicine read MDLinx article: Evidence-based Diagnostics: Adult Septic Arthritis

<< Previous Article | Next Article >>
Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Most Popular Rheumatology Articles

Last month's top read Top 50 of 2011

1 Efficacy of weekly mizoribine pulse therapy in refractory lupus nephritis Modern Rheumatology, May 9, 2012    Clinical Article

2 Impact of statin discontinuation on mortality in patients with rheumatoid arthritis - A population-based study Arthritis Care and Research , May 1, 2012    Clinical Article

3 Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials Annals of Rheumatic Diseases, May 23, 2012    Clinical Article

4 Association between systemic anti-psoriatic drugs and cardiovascular risk in patients with psoriasis and psoriatic arthritis: A nationwide cohort study Arthritis & Rheumatism, May 4, 2012    Clinical Article

5 Effectiveness of Nigella sativa Oil in the Management of Rheumatoid Arthritis Patients: A Placebo Controlled Study Phytotherapy Research, May 7, 2012    Clinical Article

6 Starting dose is a risk factor for allopurinol hypersensitivity syndrome: A proposed safe starting dose of allopurinol Arthritis & Rheumatism, April 16, 2012    Clinical Article

7 Low-dose oral prednisone improves clinical and ultrasonographic remission rates in early rheumatoid arthritis. Results of a 12 month open-label randomized study. Full Text Arthritis Research & Therapy, May 18, 2012    Free full text    Clinical Article

8 Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials Annals of Rheumatic Diseases, May 10, 2012    Clinical Article

9 Rilonacept (Interleukin-1 Trap) for prevention of gout flares during initiation of uric acid-lowering therapy: Results of the presurge-1 trial Arthritis Care and Research , May 7, 2012    Clinical Article

10 A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early, aggressive rheumatoid arthritis Arthritis & Rheumatism, April 30, 2012    Clinical Article

11 Low-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2) Annals of Rheumatic Diseases, May 10, 2012    Clinical Article

12 Sustained efficacy of certolizumab pegol added to methotrexate in the treatment of rheumatoid arthritis: 2-year results from the RAPID 1 trial Rheumatology, May 21, 2012    Clinical Article

13 Intra-Articular Glucocorticosteroid Injection into Sternocostoclavicular Joints in Patients with SAPHO Syndrome Seminars in Arthritis and Rheumatism, May 8, 2012    Clinical Article

14 Vitamin D and Bone Current Osteoporosis Reports, May 9, 2012    Clinical Article

15 A phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) versus placebo in combination with background methotrexate in patients with active rheumatoid arthritis and an inadequate response to methotrexate alone Arthritis & Rheumatism, April 24, 2012    Clinical Article

16 Mizoribine, tacrolimus, and corticosteroid combination therapy successfully induces remission in patients with lupus nephritis Clinical and Experimental Nephrology, April 17, 2012    Clinical Article

17 A review of tocilizumab treatment in 122 rheumatoid arthritis patients included in the Tsurumai Biologics Communication Registry (TBCR) Study Modern Rheumatology, May 3, 2012    Clinical Article

18 Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The Lupus Nephritis Assessment with Rituximab study Arthritis & Rheumatism, April 30, 2012    Clinical Article

19 Evidence-Based Knee Injections for the Management of Arthritis Pain Medicine, May 25, 2012    Evidence Based Medicine    Clinical Article

20 Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohns disease Annals of Rheumatic Diseases, May 24, 2012    Clinical Article

Indexed Journals in Rheumatology: Arthritis & Rheumatism, Annals of Rheumatic Diseases, Journal of Rheumatologymore

Other Topics in Rheumatology

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Edit My Newsletter Settings

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close